Selumetinib sulfate
| Selumetinib sulfate | |
|---|---|
| Term | Selumetinib sulfate |
| Short definition | Selumetinib sulfate - (pronounced) (SEL-yoo-MEH-tih-nib SUL-fayt) drug used to treat children as young as 2 years old with a rare genetic condition called neurofibromatosis type 1. It is used in patients with plexiform neurofibromas that are causing symptoms and cannot be surgically removed. |
| Type | Cancer terms |
| Specialty | Oncology |
| Language | English |
| Source | NCI |
| Comments | |
Selumetinib sulfate - (pronounced) (SEL-yoo-MEH-tih-nib SUL-fayt) drug used to treat children as young as 2 years old with a rare genetic condition called neurofibromatosis type 1. It is used in patients with plexiform neurofibromas that are causing symptoms and cannot be surgically removed. It is also being studied in the treatment of some types of cancer. Selumetinib sulfate blocks proteins called MEK1 and MEK2, which can help prevent abnormal or cancerous cells from growing. It's a kind of kinase inhibitor. Also called AZD6244, Koselugo and MEK Inhibitor AZD6244
External links
- Medical encyclopedia article on Selumetinib sulfate
- Wikipedia's article - Selumetinib sulfate
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski